KENNETT SQUARE, Pa., May 07, 2018 -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its first quarter 2018 results before the market opens on Thursday, May 10, 2018. A conference call and webcast will be held on Thursday, May 10, 2018 at 8:30 a.m. Eastern Time to discuss the results. To participate in the call, interested parties may dial (855) 849-2198 or listen to a live webcast and replay of the call on the Company’s website at http://www.genesishcc.com/investor-relations.
About Genesis HealthCare
Genesis HealthCare (NYSE:GEN) is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's largest post-acute care providers with more than 450 skilled nursing facilities and assisted/senior living communities in 30 states nationwide. Genesis subsidiaries also supply rehabilitation and respiratory therapy to approximately 1,600 healthcare providers in 46 states, the District of Columbia and China. References made in this release to "Genesis," "the Company," "we," "us" and "our" refer to Genesis HealthCare and each of its wholly-owned companies. Visit our website at www.genesishcc.com.
CONTACT:
Investor Relations
Lori Mayer, Genesis HealthCare
610-925-2000


Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
China 618 Smartphone Sales Drop 13% as Higher Prices Hurt Demand, Huawei Gains Market Share
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Shell Raises Q2 Upstream Outlook, Flags Qatar Gas Hit as Shares Rise
SpaceX Stock Draws Bullish Wall Street Coverage Ahead of Nasdaq-100 Inclusion
Barclays Downgrades Siemens Energy as Valuation Seen Near Peak
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Meta Says States Seek $1.4 Trillion in Penalties Over Teen Social Media Addiction Lawsuit
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
TetherMax Rebranding Highlights Official Exchange Partnerships and Transparent Operations
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 



